Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,072.75
-6.8508-0.33%
Number of Gainers:407
Number of Losers:593
Number of Flat:24
PE:- -
High:2,081.92
Open:2,080.01
Low:2,069.65
Close:2,079.60
Volume:4.60B
Turnover:626.92B
Market Cap:96.63T
Float Cap:90.44T

Loading ...

SLB Agrees to Buy Kelvion for $3.4 Billion, Assumes $0.7 Billion Debt

Reuters
·
Aug 31

Nikkei 225 Index Rises 3.03% This Month to 66311.93

Dow Jones
·
Aug 31

Apollo Funds Agree to Sell Kelvion to SLB for $4.1 Billion

Reuters
·
Aug 31

RBC Lifts Price Target on Broadridge Financial Solutions to $226 From $225, Keeps Outperform Rating

MT Newswires Live
·
Aug 31

Apollo Funds Agree to Sell Kelvion, a Global Leader in Cooling Solutions for Data Centers and Diversified Industrials, to Slb for $4.1 Billion

THOMSON REUTERS
·
Aug 31

Slb - Targets $4.5-$5 Bln Revenue and $700-$800 Mln Adj Ebitda for Data Center Business in 2028

THOMSON REUTERS
·
Aug 31

Slb - Expects $120 Mln Annual Ebitda Synergies Within Three Years

THOMSON REUTERS
·
Aug 31

Slb: Expects 2027 Total Returns to Shareholders to be at Least in Line with 2026 Levels

THOMSON REUTERS
·
Aug 31

Slb - Deal Expected to be Accretive to EPS and Free Cash Flow Per Share in First 12 Months

THOMSON REUTERS
·
Aug 31

Slb to Acquire Kelvion, Expanding Its Role Across Data Center Infrastructure

THOMSON REUTERS
·
Aug 31

GameStop Expects Higher 2Q Profit, Despite Lower Sales

Dow Jones
·
Aug 31

PayPal : Clear Street Cuts Target Price to $55 from $61

THOMSON REUTERS
·
Aug 31

PG&E Shares Fall on Bill Requiring Utilities to Pay More After Wildfires

Dow Jones
·
Aug 31

Lilly to Acquire Merida Biosciences in Deal Worth up to USD 2.88 Billion

Reuters
·
Aug 31

US Equity Investors to Focus on Corporate Earnings, Labor Market Health, Renewed Hostilities Against Iran This Week

MT Newswires Live
·
Aug 31

Eli Lilly: Under Terms of Agreement, Lilly Will Acquire Merida and Pay up to $2.875 Bln in Cash

THOMSON REUTERS
·
Aug 31

Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases

THOMSON REUTERS
·
Aug 31

Eli Lilly - Deal Expected to Close in Q4 2026 Subject to Regulatory Approvals

THOMSON REUTERS
·
Aug 31

Dell Technologies is Maintained at Buy by B of a Securities

Dow Jones
·
Aug 31

Ascendis Pharma Price Target Maintained with a $345.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 31